Search

Discover how MSK Monmouth is making an impact in Middletown, New Jersey.

… Wednesday, December 13, 2017 In the year since MSK Monmouth opened its doors in Middletown, New Jersey, the facility has become a vital part of the community. VIDEO | 03:45 Meet the MSK Monmouth Care Team Hear about the benefits of receiving surgery, treatment and rehabilitation close to home. Video

Updated survival outcomes from the EMBER-3 trial reinforced the clinical benefit of imlunestrant-based regimens as all-oral, chemotherapy-free treatment options for endocrine-pretreated patients with estrogen receptor-positive, human epidermal growth factor receptor 2-negative advanced or metastatic breast cancer. Breast medical oncologist Komal Jhaveri, MD, FACP, presented the latest results for the trial at SABCS, and was also the lead and corresponding author of the paper published simultaneously in the Annals of Oncology.

… Friday, December 12, 2025 Updated survival outcomes from the EMBER-3 trial reinforced the clinical benefit of imlunestrant as monotherapy and in combination with abemaciclib as oral, chemotherapy-free treatment options for patients with estrogen receptor (ER)-positive, human epidermal growth factor receptor

The three recipients of the 2023 Paul Marks Prize for Cancer Research will present their research at a symposium. Learn about the research of Mark Agnel Frederick Dawson, Cigall Kadoch, and Michelle Monje,

… Monday, March 18, 2024 The three recipients of the 2023  Paul Marks Prize for Cancer Research will present their research at a symposium to be held March 26, 2024. The prize was named in honor of the late  Paul A. Marks, MD , President Emeritus of Memorial Sloan Kettering Cancer Center (MSK). It recognizes

Get to know Florisela Herrejon Chavez, a cancer biology graduate student in the Gerstner Sloan Kettering School of Biomedical Sciences.

… Wednesday, March 25, 2020 Summary As part of Women’s History Month, we are profiling some of MSK’s star female graduate students and postdoctoral fellows training to be leaders in their fields. Florisela Herrejon Chavez is a graduate student in the Kharas lab  in the Sloan Kettering Institute. When and

On July 22, 2021, Memorial Sloan Kettering Cancer Center was prominently featured on NBC News/The Today Show about “How to Navigate Nation’s Top Hospitals.”

… Thursday, July 22, 2021 On July 22, 2021, Memorial Sloan Kettering Cancer Center was prominently featured on NBC News/The Today Show about “ How to Navigate Nation’s Top Hospitals .” The segment positioned MSK as a leader in cancer care while highlighting our specialized care and personal approach and

Lymphoma experts Anas Younes, MD and Andrew Zelenetz, MD, PhD discuss the fast evolving research on CAR T cells and checkpoint inhibitors that is yielding the novel treatment options improving both outcomes and quality of life for people with lymphoma.

… Wednesday, May 16, 2018 VIDEO | 05:17 Lymphoma Update: CAR T Therapies and Checkpoint Inhibitors Lymphoma experts Anas Younes, MD and Andrew Zelenetz, MD, PhD discuss the fast evolving research on CAR T cells and checkpoint inhibitors that is yielding the novel treatment options improving both outcomes

A new MSK-led study used single-cell sequencing and other techniques to examine a phenomenon known as “whole-genome doubling” in high-grade serous ovarian carcinoma (HGSOC), the most common and aggressive form of ovarian cancer. The insights could help researchers develop more effective treatment strategies.

… Wednesday, July 16, 2025 Research led by Memorial Sloan Kettering Cancer Center (MSK) is shedding new light on how ovarian cancer evolves — insights that could help researchers develop more effective treatment strategies. While ovarian cancer diagnoses and deaths have decreased over recent decades ,

Memorial Sloan Kettering Cancer Center (MSK) announces its most recent awards and appointments for the institution’s physicians, scientists, nurses, and staff.

… Monday, May 17, 2021 Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments: Larry Norton Elected to the American Academy of Arts & Sciences Larry Norton Larry Norton, MD , Senior Vice President, Office of the President; Medical Director, Evelyn H. Lauder Breast

Discovery reveals that the genetic causes of cancer may be more complicated than previously thought.

… Wednesday, May 27, 2020 Summary It turns out that finding driver mutations may be more complicated than previously thought: Nearly a quarter of all tumors have two different mutations in the same gene. A major effort in cancer research is the search for driver mutations in tumors. These mutations are

The PICI@MSK fellowship will provide Dr. Delconte with two years of financial support for her research on natural killer cells in cancer.

… Wednesday, March 17, 2021 Rebecca Delconte is a postdoctoral fellow working in the lab of immunologist Joseph Sun in the Sloan Kettering Institute. She is the recipient of the 2021-2022 Parker Institute for Cancer Immunotherapy at MSK  Postdoctoral Fellowship, which will provide two years of financial